BSE filing, NSE: ASPIRA. Summary written from the filing by ALFA Finder's alert engine.
Aspira Pathlab & Diagnostics Ltd: key numbers
- Share price
- ₹127.45
- Market cap
- ₹131.2 Cr
- Revenue (annual)
- ₹24.98 Cr
- Net profit (annual)
- ₹0.05 Cr
- P/E (TTM)
- -289.8×Sector 52.3×
- Promoter holding
- 46.65%+0.07% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aspira Pathlab & Diagnostics Ltd
All →Aspira Pathlab & Diagnostics Other Announcement
Aspira Pathlab & Diagnostics Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Listing Regulations.
Aspira Pathlab & Diagnostics Promoter Buying: ₹0.02 Cr
Promoter Jay Arvind Bhanushali acquired 1,424 equity shares of Aspira Pathlab & Diagnostics Ltd via market purchase. The transaction is valued at ₹0.02 Crore.
- Value
- ₹0.02 Cr
- Promoter stake change
- +0.01%
Aspira Pathlab & Diagnostics Promoter Buying
Promoter Jay Arvind Bhanushali acquired 1,424 shares of Aspira Pathlab & Diagnostics Ltd via the open market. This transaction increased the promoter's stake from 7.27% to 7.28%.
- Execution
- 17-09-2026 to 24-09-2026
- Promoter stake change
- +0.01%
Aspira Pathlab & Diagnostics Annual General Meeting
Aspira Pathlab & Diagnostics held its 53rd Annual General Meeting on September 25, 2026, where members deliberated on financial statements and various directorial appointments.
Aspira Pathlab & Diagnostics Promoter Buying: ₹0.01 Cr
Promoter Jay Arvind Bhanushali acquired 1,387 equity shares of Aspira Pathlab & Diagnostics Ltd through market purchase, increasing their stake from 7.25% to 7.27%.
- Value
- ₹0.01 Cr
- Promoter stake change
- +0.02%
Aspira Pathlab & Diagnostics Promoter Buying
Promoter Jay Arvind Bhanushali acquired 1,387 shares of Aspira Pathlab & Diagnostics Ltd via an open-market transaction, increasing his stake by 0.02%.
- Promoter stake change
- +0.02%
Other open offer announcements
All →Kronox Lab Sciences Open Offer: ₹150.5 Cr
Indo Borax and Zenrock filed the Letter of Offer for up to 95.70 lakh Kronox Lab shares at ₹157.27. The offer covers 25.79% of voting capital.
- Value
- ₹150.5 Cr
- Execution
- Tendering Period opens November 06, 2026 and closes November 20, 2026 (revised schedule)
IIFL Capital Services Open Offer: ₹3,505 Cr
FIH Mauritius and HWIC launched a 26% open offer for IIFL Capital Services at Rs.350 per share. Up to Rs.3,505 Crore; tendering opens November 2.
- Value
- ₹3,505 Cr
Comrade Appliances Open Offer: ₹9.26 Cr
Manager Corporate Professionals filed the draft letter of offer for a mandatory open offer for Comrade Appliances by four acquirers. They seek up to 26.46 lakh shares, 26% of expanded capital, at Rs 35 per share.
- Value
- ₹9.26 Cr
Genomic Valley Biotech Open Offer: ₹57.97 Cr
Manager to the Open Offer filed GVB's DPS announcing an open offer for up to 7,94,170 shares at ₹730. The Acquirers seek about 21% of the company.
- Value
- ₹57.97 Cr
Inani Securities Open Offer: ₹7.11 Cr
Aikyam Financial Services is acquiring 11.85 lakh Inani Securities shares at ₹60 each via SAST open offer. The DLOO was submitted to BSE for processing.
- Value
- ₹7.11 Cr
Kuber Udyog Open Offer: ₹74.65 Cr
Manager to the Offer filed Pre-Offer PA for an open offer to acquire 26% of Kuber Udyog at ₹23.35 per share. Tendering period begins October 28, 2026.
- Value
- ₹74.65 Cr